Multiple SclerosisNCT06769763
mHealth Effect on Multiple Sclerosis Patients' Quality of Life and Self-care Practices
A study testing My Journey with MS application in people with Multiple Sclerosis, run by Cairo University at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to learn if an Arabic mobile application for multiple sclerosis patients will improve self-care practice and the quality of life of patients or not. Read more about this study
- Who is it for?
- Ages 18 to 50 years
- Conditions the study is for
- Multiple Sclerosis
- What is being tested?
- My Journey with MS application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 74 participants
- Where
- 1 siteEgypt
- Study dates
- 14 Jan 2025to 15 Sep 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Diagnosed clinically with multiple sclerosis.
- From 18 to 50 years old (adult).
- With smartphones.
- Willing to participate in the study and use the mobile application.
Who cannot join
- Patients who are bedridden or in a wheelchair
- Illiterate patients.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Arabic Mobile Application for Multiple Sclerosis (MS) Patients and Its Effect on Their Quality of Life and Self-care Practices
The goal of this clinical trial is to learn if an Arabic mobile application for multiple sclerosis patients will improve self-care practice and the quality of life of patients or not. The main question it aims to answer is:
Does the Arabic mobile application for MS patients will improve their self-care and quality of life?
Participants will:
Use the developed application or usual care without using the application for 3 months Be followed up during the 12 week period and asked to follow the instructions in the application
Read the detailed description
This study aims to build and test a culturally appropriate mobile application in Arabic for MS (multiple sclerosis) patients in Egypt. It will focus on self-care practices and quality of life enhancement via educational material provision, symptom tracking as well as medication adherence reminders among other possible functions depending on user preferences. The study shall evaluate how effective the developed app is in promoting self-care practices and improving the quality of life for MS patients compared to a control group who do not use the app.
- Conditions
- Multiple Sclerosis
- Being tested
- My Journey with MS application
- Keywords
- Multiple sclerosis, Quality of life, Self-care, mHealth, Arabic Application
- Medical subject headings
- Multiple Sclerosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
My Journey with MS applicationOther
This is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders.
| Study group | Role | What they receive |
|---|---|---|
| App users | Active comparator | This arm is the interventional group who will use the application for 3 months Receives: Other: My Journey with MS application |
| Control arm | No intervention | This arm will not use the application during the period of follow-up. |
What is being measured
The primary outcome is the main question the study is designed to answer.
The effect of mHealth on the self-care practices of multiple sclerosis patients
The effect of mHealth on the self-care practices of multiple sclerosis patients will be assessed using the self-care for chronic disease inventory questionnaire. The score ranges from 0 to 100, the higher the score the better the self-care practices.
Measured: From enrollment to the end of follow-up at 12 weeks
The effect of mHealth on the quality of life of multiple sclerosis patients
The effect of mHealth on the quality of life (QoL) of multiple sclerosis patients will be assessed using the multiple sclerosis international quality of life (Musiqol) questionnaire. The score will be transformed into a range from 0 to 100; the higher the score, the better the QoL practices.
Measured: From enrollment to the end of follow-up at 12 weeks
Secondary outcomes (1)
The usability of the developed application
The usability of the developed application will be assessed using the app usability questionnaire. The patients will choose a number between 1 to 7 (Likert scale), as 1 strongly disagree, 2 disagree, 3 somewhat disagree 4 neutral, 5 somewhat agree, 6 agree, and 7 strongly agree. Then the total average of all scored items for each participant will be calculated; the higher the average, the better the app's usability
Measured: After 12 weeks of enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2025
- Study start14 Jan 2025
- Primary completion10 Jun 2025
- Study completion15 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Multiple SclerosisStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 74 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aya Emeash, Cairo University
- Investigators
- Nargis Albert Labib, Study chair, Professor of public Health and Community Medicine, Faculty of Medicine, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06769763
- Sponsor's protocol ID
- MD-204-2024
- Status last verified
- Mar 2026
- First submitted
- 9 Jan 2025
- Last updated
- 20 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The information may not be shared if it violates the data's confidentiality, and can't be ensured that it will not be used for purposes not present in the consent form.
Study at a glance
From the registry record, last updated by the sponsor on 20 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Arabic Mobile Application for Multiple Sclerosis (MS) Patients and Its Effect on Their Quality of Life and Self-care Practices
- ClinicalTrials.gov ID
- NCT06769763
- Acronym / sponsor ID
- MD-204-2024
- Conditions
- Multiple Sclerosis
- Keywords
- Multiple sclerosis, Quality of life, Self-care, mHealth, Arabic Application
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 74 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 14 Jan 2025 (actual)
- Primary completion
- 10 Jun 2025 (actual)
- Study completion
- 15 Sep 2025 (actual)
- First posted
- 10 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if an Arabic mobile application for multiple sclerosis patients will improve self-care practice and the quality of life of patients or not. The main question it aims to answer is:
Does the Arabic mobile application for MS patients will improve their self-care and quality of life?
Participants will:
Use the developed application or usual care without using the application for 3 months Be followed up during the 12 week period and asked to follow the instructions in the application
Detailed description
This study aims to build and test a culturally appropriate mobile application in Arabic for MS (multiple sclerosis) patients in Egypt. It will focus on self-care practices and quality of life enhancement via educational material provision, symptom tracking as well as medication adherence reminders among other possible functions depending on user preferences. The study shall evaluate how effective the developed app is in promoting self-care practices and improving the quality of life for MS patients compared to a control group who do not use the app.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| App users | Active comparator | Other: My Journey with MS applicationThis arm is the interventional group who will use the application for 3 months |
| Control arm | No intervention | –This arm will not use the application during the period of follow-up. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Diagnosed clinically with multiple sclerosis.
- From 18 to 50 years old (adult).
- With smartphones.
- Willing to participate in the study and use the mobile application.
Key exclusion criteria (2 listed)
- Patients who are bedridden or in a wheelchair
- Illiterate patients.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| My Journey with MS applicationThis is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders. | Other | App users |
Primary outcome
The effect of mHealth on the self-care practices of multiple sclerosis patients
Time frame: From enrollment to the end of follow-up at 12 weeks
The effect of mHealth on the self-care practices of multiple sclerosis patients will be assessed using the self-care for chronic disease inventory questionnaire. The score ranges from 0 to 100, the higher the score the better the self-care practices.
The effect of mHealth on the quality of life of multiple sclerosis patients
Time frame: From enrollment to the end of follow-up at 12 weeks
The effect of mHealth on the quality of life (QoL) of multiple sclerosis patients will be assessed using the multiple sclerosis international quality of life (Musiqol) questionnaire. The score will be transformed into a range from 0 to 100; the higher the score, the better the QoL practices.
1 secondary outcome
The usability of the developed application
Time frame: After 12 weeks of enrollment
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Mar 2026.
- Individual participant dataSharing planned: No. The information may not be shared if it violates the data's confidentiality, and can't be ensured that it will not be used for purposes not present in the consent form.
Related trials for Multiple Sclerosis
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Multiple Sclerosis
RecruitingPhase 2
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nargis Albert Labib study chair
Professor of public Health and Community Medicine, Faculty of Medicine, Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing My Journey with MS application in people with Multiple Sclerosis, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The effect of mHealth on the self-care practices of multiple sclerosis patients (time frame: From enrollment to the end of follow-up at 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.